Diaminopyrimidines as P2X3 and P3X2/3 modulators

Details for Australian Patent Application No. 2006286576 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Dillon, Michael Patrick; Jahangir, Alam; Lui, Alfred Sui-Ting; Wilhelm, Robert Stephen

Agent Spruson & Ferguson

Pub. Number AU-B-2006286576

PCT Pub. Number WO2007/025900

Priority 60/713,243 01.09.05 US

Filing date 21 August 2006

Wipo publication date 8 March 2007

Acceptance publication date 14 June 2012

International Classifications

C07D 239/48 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 13/00 (2006.01) Drugs for disorders of the urinary system

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

20 March 2008 PCT application entered the National Phase

  PCT publication WO2007/025900 Priority application(s): WO2007/025900

14 June 2012 Application Accepted

  Published as AU-B-2006286576

11 October 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006286601-Diaminopyrimidines as P2X3 and P2X2/3 modulators

2006286573-Benzooxazole, oxazolopyridine, benzothiazole and thiazolopyridine derivatives